26.58BMarket Cap-81117P/E (TTM)
30.900High29.500Low2.45MVolume29.600Open30.000Pre Close73.98MTurnover0.28%Turnover Ratio33.74P/E (Static)871.47MShares35.90052wk High4.60P/B26.58BFloat Cap19.00052wk Low--Dividend TTM871.47MShs Float85.800Historical High--Dividend LFY4.67%Amplitude11.360Historical Low30.210Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
HUTCHMED Stock Forum
$Hutchmed (China) (HCM.US)$
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3 ...
According to the ac...
No comment yet